Takeda Pharmaceutical (TAK) Asset Utilization Ratio (2018 - 2026)

Takeda Pharmaceutical's Asset Utilization Ratio history runs 9 years deep, the most recent figure standing at 0.46 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 3.15% year-over-year to 0.46; the TTM figure through Mar 2026 stood at 0.46 (down 3.15% YoY), while the FY2026 annual figure was 0.31, up 0.59% from the prior year.
• Asset Utilization Ratio was 0.46 for Q1 2026 at Takeda Pharmaceutical, down from 0.47 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.49 in Q2 2025 to a low of 0.28 in Q2 2022.
• Historically, Asset Utilization Ratio has averaged 0.37 across 5 years, with a median of 0.31 in 2023.
• The sharpest annual moves came in 2025 and 2026: Asset Utilization Ratio surged 70.44% in 2025, then dropped 3.15% in 2026.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.31 in 2022, then retreated by 0.21% to 0.31 in 2023, then jumped by 50.38% to 0.46 in 2024, then grew by 3.04% to 0.47 in 2025, then slipped by 2.16% to 0.46 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.46 (Q1 2026), 0.47 (Q4 2025), and 0.48 (Q3 2025), per Business Quant data.